.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The WOMAN trial randomized more than 20,000 women with postpartum hemorrhage to tranexamic acid or placebo. Overall, tranexamic acid did not significantly reduce the composite of all-cause mortality or hysterectomy, but it significantly reduced death due to bleeding, particularly when treatment was given within 3 hours of childbirth. No increase in thromboembolic events was identified. The practical implication for obstetric teams is that timing matters: tranexamic acid is most useful as an early component of a broader postpartum-hemorrhage response rather than as a late rescue measure. Clinicians still need simultaneous uterotonic therapy, uterine assessment, blood-product support when indicated and rapid identification of trauma, retained tissue or coagulopathy. The trial helped move tranexamic acid from a specialist or optional intervention toward a standard evidence-based component of PPH management. It is especially relevant to simulation training because effective response depends on recognition, protocol activation and coordinated multidisciplinary action.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The WOMAN trial randomized more than 20,000 women with postpartum hemorrhage to tranexamic acid or placebo. Overall, tranexamic acid did not significantly reduce the composite of all-cause mortality or hysterectomy, but it significantly reduced death due to bleeding, particularly when treatment was given within 3 hours of childbirth. No increase in thromboembolic events was identified. The practical implication for obstetric teams is that timing matters: tranexamic acid is most useful as an early component of a broader postpartum-hemorrhage response rather than as a late rescue measure. Clinicians still need simultaneous uterotonic therapy, uterine assessment, blood-product support when indicated and rapid identification of trauma, retained tissue or coagulopathy. The trial helped move tranexamic acid from a specialist or optional intervention toward a standard evidence-based component of PPH management. It is especially relevant to simulation training because effective response depends on recognition, protocol activation and coordinated multidisciplinary action.
last month
Researchers have developed a validated gradient boosting machine learning tool to predict primary tumor origin in cancer of unknown primary using clinical and metastatic variables, achieving high accuracy without initial pathology or genomic testing.
2 days back
An all-printed immunosensing microchip detects urinary sFlt-1 in just 10 minutes with 3.61 pg/mL sensitivity. By leveraging photonic bandgap engineering, this low-cost, cleanroom-free platform provides non-invasive preeclampsia screening, offering substantial benefits for point-of-care obstetric triage.
2 days back
Wearable ultrasound patches are transforming healthcare by shifting medicine from episodic evaluations to continuous monitoring. Discover how flexible acoustic transducers advance cardiovascular tracking, musculoskeletal imaging, neuromodulation, and on-demand closed-loop theranostics.
2 days back
A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
Last week
Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
Last week
